201 related articles for article (PubMed ID: 25178484)
21. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
22. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
Walsh AM; Lazzara MJ
Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
[TBL] [Abstract][Full Text] [Related]
23. Smad7 Modulates Epidermal Growth Factor Receptor Turnover through Sequestration of c-Cbl.
Ha Thi HT; Kim HY; Choi SW; Kang JM; Kim SJ; Hong S
Mol Cell Biol; 2015 Aug; 35(16):2841-50. PubMed ID: 26055326
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
[TBL] [Abstract][Full Text] [Related]
25. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes.
Zhang B; Srirangam A; Potter DA; Roman A
Oncogene; 2005 Apr; 24(15):2585-8. PubMed ID: 15735736
[TBL] [Abstract][Full Text] [Related]
26. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
27. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
Parks EE; Ceresa BP
J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation.
Wehrle C; Van Slyke P; Dumont DJ
Biochem J; 2009 Oct; 423(3):375-80. PubMed ID: 19689429
[TBL] [Abstract][Full Text] [Related]
29. A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation.
Pennock S; Wang Z
Mol Cell Biol; 2008 May; 28(9):3020-37. PubMed ID: 18316398
[TBL] [Abstract][Full Text] [Related]
30. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
Aoki Y; Niihori T; Banjo T; Okamoto N; Mizuno S; Kurosawa K; Ogata T; Takada F; Yano M; Ando T; Hoshika T; Barnett C; Ohashi H; Kawame H; Hasegawa T; Okutani T; Nagashima T; Hasegawa S; Funayama R; Nagashima T; Nakayama K; Inoue S; Watanabe Y; Ogura T; Matsubara Y
Am J Hum Genet; 2013 Jul; 93(1):173-80. PubMed ID: 23791108
[TBL] [Abstract][Full Text] [Related]
31. Intersectin 1 enhances Cbl ubiquitylation of epidermal growth factor receptor through regulation of Sprouty2-Cbl interaction.
Okur MN; Ooi J; Fong CW; Martinez N; Garcia-Dominguez C; Rojas JM; Guy G; O'Bryan JP
Mol Cell Biol; 2012 Feb; 32(4):817-25. PubMed ID: 22158968
[TBL] [Abstract][Full Text] [Related]
32. Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42.
Hirsch DS; Shen Y; Wu WJ
Cancer Res; 2006 Apr; 66(7):3523-30. PubMed ID: 16585176
[TBL] [Abstract][Full Text] [Related]
33. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
34. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
35. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling.
Azakir BA; Angers A
Cell Signal; 2009 Aug; 21(8):1326-36. PubMed ID: 19341794
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.
Pérez B; Mechinaud F; Galambrun C; Ben Romdhane N; Isidor B; Philip N; Derain-Court J; Cassinat B; Lachenaud J; Kaltenbach S; Salmon A; Désirée C; Pereira S; Menot ML; Royer N; Fenneteau O; Baruchel A; Chomienne C; Verloes A; Cavé H
J Med Genet; 2010 Oct; 47(10):686-91. PubMed ID: 20543203
[TBL] [Abstract][Full Text] [Related]
37. Clinical manifestations of mutations in RAS and related intracellular signal transduction factors.
Zenker M
Curr Opin Pediatr; 2011 Aug; 23(4):443-51. PubMed ID: 21750428
[TBL] [Abstract][Full Text] [Related]
38. Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.
Okur MN; Russo A; O'Bryan JP
Mol Cell Biol; 2014 Jan; 34(2):271-9. PubMed ID: 24216759
[TBL] [Abstract][Full Text] [Related]
39. [A new "rasopathy": mutation in the CBL tumour-suppressor gene in neuro-cardio-facio-cutaneous syndrome similar to Noonan syndrome].
Dereure O
Ann Dermatol Venereol; 2011 Jan; 138(1):75-6. PubMed ID: 21276471
[No Abstract] [Full Text] [Related]
40. [Ubiquitination of EGF receptors with C-terminal domain deletion and point mutations during endocytosis].
Kondratov KA; Melikova MS; Chernorudskiĭ AL; Kornilova ES
Tsitologiia; 2009; 51(7):617-23. PubMed ID: 19764654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
